- Previous Close
6.92 - Open
6.82 - Bid 6.86 x --
- Ask 7.14 x --
- Day's Range
6.82 - 6.82 - 52 Week Range
6.38 - 9.20 - Volume
260 - Avg. Volume
10 - Market Cap (intraday)
167.453M - Beta (5Y Monthly) 0.69
- PE Ratio (TTM)
21.31 - EPS (TTM)
0.32 - Earnings Date May 13, 2025 - May 19, 2025
- Forward Dividend & Yield 0.14 (2.02%)
- Ex-Dividend Date Apr 22, 2025
- 1y Target Est
--
Fine Foods & Pharmaceuticals N.T.M. S.p.A. engages in the contract development and manufacturing of drugs, food supplements, and other nutraceutical products and medical devices for the pharmaceutical and nutraceutical industries. It offers pharmaceutical products, including powders, soluble, effervescent and chewable granules, filmed and effervescent tablets, fast melting/sublingual tablets, film-coated tablets, and hard gelatine capsules in various types of packaging, such as sachets, sticks, pillboxes, jars, blisters, tubes, and strips for various therapeutic areas, such as probiotics, multivitamins and minerals, immune systems, sleep and relax, gastrointestinal system, circulatory system, osteoarticular system, urinary system, women health, beauty, healthy ageing, and mental wellbeing. In addition, the company is involved in the production, marketing, research, and development of cosmetics products comprising liquid detergents for personal hygiene, hair care, skin care, bath and shower gels, shampoo and conditioners, shaping waxes, mouthwash and breath products, creams, gel and toothpaste, roll-on, stick and vapo spray deodrants, intimate cleansers, emulsions and microemulsions, gels, liquid soaps, skin care emulsions, oral hygiene, deodorants, and alcohol-based perfumery products in packaging, including coextruded and laminated tubes, aluminium tubes, special packs, lip sticks, air less, and various bottles and jars under its own and third-party brands. It operates in Italy, Germany, France, the United Kingdom, Spain, Greece, and internationally. The company was founded in 1984 and is headquartered in Verdellino, Italy.
www.finefoods.it779
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 9S5.F
View MorePerformance Overview: 9S5.F
Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is FTSE MIB Index (FTSEMIB.MI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 9S5.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 9S5.F
View MoreValuation Measures
Market Cap
169.91M
Enterprise Value
205.23M
Trailing P/E
21.62
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.73
Price/Book (mrq)
1.28
Enterprise Value/Revenue
0.84
Enterprise Value/EBITDA
6.64
Financial Highlights
Profitability and Income Statement
Profit Margin
3.34%
Return on Assets (ttm)
3.73%
Return on Equity (ttm)
6.30%
Revenue (ttm)
244.36M
Net Income Avi to Common (ttm)
8.16M
Diluted EPS (ttm)
0.32
Balance Sheet and Cash Flow
Total Cash (mrq)
19.21M
Total Debt/Equity (mrq)
41.29%
Levered Free Cash Flow (ttm)
9.28M